About $1.1 billion flowed into healthcare/biotech funds in the second quarter, resulting in a net inflow of $1.6 billion for the first half. This compares to a net outflow of $13.6 billion from all equity funds in 1H12. Monthly fund flows data as of June 25. Source: EPFR Global